Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-30 4:32 pm Sale |
2024-08-30 | 13G | RumbleON, Inc. RMBL |
Nantahala Capital Management, LLC | 3,066,537 8.700% |
-1,349,969 (-30.57%) |
Filing History |
| 2024-07-03 2:02 pm Purchase |
2024-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Management, LLC | 1,962,070 15.100% |
1,962,070 (New Position) |
Filing History |
| 2024-06-18 4:30 pm Unchanged |
2024-06-14 | 13D | Aytu BioPharma, Inc. AYTU |
Nantahala Capital Management, LLC | 1,086,812 18.200% |
0 (Unchanged) |
Filing History |
| 2024-03-11 4:06 pm Purchase |
2024-02-29 | 13G | Rezolute, Inc. RZLT |
Nantahala Capital Management, LLC | 4,118,164 9.900% |
4,118,164 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | The RMR Group Inc. RMR |
Nantahala Capital Management, LLC | 404,063 2.600% |
-554,211 (-57.83%) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Nantahala Capital Management, LLC | 1,952,368 5.100% |
1,952,368 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Nantahala Capital Management, LLC | 77,337 1.700% |
-141,036 (-64.58%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management, LLC | 372,562 4.200% |
-158,642 (-29.86%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | IMAX Corporation IMAX |
Nantahala Capital Management, LLC | 2,658,753 4.900% |
-2,329,436 (-46.70%) |
Filing History |
| 2024-02-14 4:51 pm Unchanged |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Nantahala Capital Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Bioventus Inc. BVS |
Nantahala Capital Management, LLC | 5,977,471 9.500% |
5,977,471 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Codexis, Inc. CDXS |
Nantahala Capital Management, LLC | 4,592,903 6.600% |
105,121 (+2.34%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | DHI Group, Inc. DHX |
Nantahala Capital Management, LLC | 2,639,687 5.600% |
-1,022,289 (-27.92%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Luxfer Holdings PLC LXFR |
Nantahala Capital Management, LLC | 1,809,645 6.700% |
-642,674 (-26.21%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Red Violet, Inc. RDVT |
Nantahala Capital Management, LLC | 1,205,678 8.600% |
-69,410 (-5.44%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | STRATA Skin Sciences, Inc. SSKN |
Nantahala Capital Management, LLC | 312,813 8.900% |
-126,555 (-28.80%) |
Filing History |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | uniQure N.V. QURE |
Nantahala Capital Management, LLC | 3,158,027 6.600% |
-729,912 (-18.77%) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Assertio Holdings, Inc. ASRT |
Nantahala Capital Management, LLC | 7,619,440 8.000% |
7,619,440 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Evolus, Inc. EOLS |
Nantahala Capital Management, LLC | 2,910,849 5.100% |
2,910,849 (New Position) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Gaia, Inc. GAIA |
Nantahala Capital Management, LLC | 915,029 5.200% |
915,029 (New Position) |
Filing History |